Related Experiment Videos

[Hypertension in advanced age]

Mirosław Kroczak1

  • 1NZOZ Centrum Dializ, Fresenius NephroCare, Stacja Dializ w Sieradzu.

Polskie Archiwum Medycyny Wewnetrznej
|January 27, 2005
PubMed

Insights

Isolated Systolic Hypertension (ISH) affects over half of elderly patients. Successful ISH therapy requires accurate blood pressure measurement, correct diagnosis, and individualized treatment plans using a "start low, go slow" approach.

Area of Science:

  • Geriatric Medicine
  • Cardiovascular Disease
  • Hypertension Management

Context:

  • Hypertension is prevalent in over 50% of the elderly population.
  • Isolated Systolic Hypertension (ISH) is the most common form of hypertension in this demographic.
  • Effective management of ISH in the elderly is crucial due to its significant health implications.

Purpose:

  • To emphasize the importance of successful therapeutic strategies for Isolated Systolic Hypertension in elderly patients.
  • To highlight key components of effective ISH management.
  • To advocate for a personalized and cautious approach to pharmacotherapy.

Summary:

  • Accurate arterial blood pressure measurement is fundamental for diagnosing ISH.
  • Correct diagnosis of ISH is essential for initiating appropriate treatment.
  • Individualized therapy protocols, adhering to the "start low, go slow" principle, are vital for successful ISH management in the elderly.

Impact:

  • Improved patient outcomes through effective hypertension control.
  • Reduced risk of cardiovascular events associated with uncontrolled ISH.
  • Enhanced quality of life for elderly patients managing hypertension.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...